α 1-Adrenoceptors are required for normal male sexual function

British Journal of Pharmacology

Volumn 152, Issue 3, 2007, Pages 332-340

  Sanbe, A ^a   Tanaka, Y ^b   Fujiwara, Y ^a   Tsumura, H ^a   Yamauchi, J ^a   Cotecchia, S ^c   Koike, K ^b   Tsujimoto, G ^d   Tanoue, A ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b TOHO UNIVERSITY   (Japan)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

1 Adrenoceptor; Ejaculation; Vas deferens

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; NORADRENALIN; RECEPTOR SUBTYPE; ADRENERGIC RECEPTOR ALPHA(1A); ADRENERGIC RECEPTOR ALPHA(1B); ADRENERGIC RECEPTOR ALPHA(1D); ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; EJACULATION; ELECTROSTIMULATION; FEMALE; FERTILITY; KNOCKOUT MOUSE; MALE; MOUSE; MUSCLE CONTRACTILITY; NONHUMAN; PREGNANCY RATE; PRIORITY JOURNAL; SEXUAL FUNCTION; VAS DEFERENS; ANIMAL; C57BL MOUSE; DRUG EFFECT; GENETICS; METABOLISM; MOUSE MUTANT; MUSCLE CONTRACTION; PHYSIOLOGY; PREGNANCY; SPERM;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; EJACULATION; ELECTRIC STIMULATION; FEMALE; FERTILITY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE CONTRACTION; PREGNANCY; RECEPTORS, ADRENERGIC, ALPHA-1; SEMEN; VAS DEFERENS;

EID: 34848847899     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707366     Document Type: Article

References (39)

1. ALLHAT Collaborative Research Group (2000). Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 283: 1967-1975.
2. Ban Y, Sato T, Nakatsuka T, Kemi M, Samura K, Matsumoto H et al. (2002). Impairment of male fertility induced by muscarinic receptor antagonists in rats. Reprod Toxicol 16: 757-765.
3. Burcelin R, Uldry M, Foretz M, Perrin C, Dacosta A, Nenniger-Tosato M et al. (2004). Impaired glucose homeostasis in mice lacking the alpha1b-adrenergic receptor subtype. J Biol Chem 279: 1108-1115.
4. Cavalli A, Lattion AL, Hummler E, Nenniger M, Pedrazzini T, Aubert JF et al. (1997). Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor. Proc Natl Acad Sci USA 94: 11589-11594.
5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. (2003). The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289: 2560-2572.
6. Cleary L, Slattery J, Bexis S, Docherty JR (2004). Sympathectomy reveals alpha 1A- and alpha 1D-adrenoceptor components to contractions to noradrenaline in rat vas deferens. Br J Pharmacol 143: 745-752.
7. Cleary L, Vandeputte C, Docherty JR (2003). Investigation of postjunctional alpha1- and alpha2-adrenoceptor subtypes in vas deferens from wild-type and alpha(2A/D)-adrenoceptor knockout mice. Br J Pharmacol 138: 1069-1076.
8. Cohn JN (1988). Effect of vasodilator therapy on mortality in chronic congestive heart failure. Eur Heart J 9 (Suppl A): 171-173.
9. Cuprian AM, Solanki P, Jackson MV, Cunnane TC (2005). Cholinergic innervation of the mouse isolated vas deferens. Br J Pharmacol 146: 927-934.
10. Debruyne FM (2000). Alpha blockers: are all created equal? Urology 56: 20-22.
11. Drouin C, Darracq L, Trovero F, Blanc G, Glowinski J, Cotecchia S et al. (2002). Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J Neurosci 22: 2873-2884.
12. Foglar R, Shibata K, Horie K, Hirasawa A, Tsujimoto G (1995). Use of recombinant alpha 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy. Eur J Pharmacol 288: 201-207.
13. Furukawa K, Rosario DJ, Smith DJ, Chapple CR, Uchiyama T, Chess-Williams R (1995). Alpha 1A-adrenoceptor-mediated contractile responses of the human vas deferens. Br J Pharmacol 116: 1605-1610.
14. Guarino RD, Perez DM, Piascik MT (1996). Recent advances in the molecular pharmacology of the alpha 1-adrenergic receptors. Cell Signal 8: 323-333.
15. Guh JH, Chueh SC, Ko FN, Teng CM (1995). Characterization of alpha 1-adrenoceptor subtypes in tension response of human prostate to electrical field stimulation. Br J Pharmacol 115: 142-146.
16. Han C, Abel PW, Minneman KP (1987a). Alpha 1-adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscle. Nature 329: 333-335.
17. Han C, Abel PW, Minneman KP (1987b). Heterogeneity of alpha 1-adrenergic receptors revealed by chlorethylclonidine. Mol Pharmacol 32: 505-510.
18. Hellstrom WJ, Sikka SC (2006). Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers. J Urol 176: 1529-1533.
19. Hisasue S, Furuya R, Itoh N, Kobayashi K, Furuya S, Tsukamoto T (2006). Ejaculatory disorder caused by alpha-1 adrenoceptor antagonists is not retrograde ejaculation but a loss of seminal emission. Int J Urol 13: 1311-1316.
20. Hosoda C, Koshimizu TA, Tanoue A, Nasa Y, Oikawa R, Tomabechi T et al. (2005a). Two alpha1-adrenergic receptor subtypes regulating the vasopressor response have differential roles in blood pressure regulation. Mol Pharmacol 67: 912-922.
21. Hosoda C, Tanoue A, Shibano M, Tanaka Y, Hiroyama M, Koshimizu TA et al. (2005b). Correlation between vasoconstrictor roles and mRNA expression of alpha1-adrenoceptor subtypes in blood vessels of genetically engineered mice. Br J Pharmacol 146: 456-466.
22. Joyce KL, Porcelli J, Cooke PS (1993). Neonatal goitrogen treatment increases adult testis size and sperm production in the mouse. J Androl 14: 448-455.
23. Kawabe K, Yoshida M, Homma Y (2006). Silodosin, a new alpha(1A)-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men. BJU Int 98: 1019-1024.
24. Mallard NJ, Marshall RW, Sithers AJ, Spriggs TL (1992). Separation of putative alpha 1A- and alpha 1B-adrenoceptor mediated components in the tension response of the rat vas deferens to electrical field stimulation. Br J Pharmacol 105: 727-731.
25. McGrath JC (1982). Evidence for more than one type of postjunctional alpha-adrenoceptor. Biochem Pharmacol 31: 467-484.
26. Mulryan K, Gitterman DP, Lewis CJ, Vial C, Leckie BJ, Cobb AL et al. (2000). Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature 403: 86-89.
27. Noble AJ, Chess-Williams R, Couldwell C, Furukawa K, Uchyiuma T, Korstanje C et al. (1997). The effects of tamsulosin, a high affinity antagonist at functional alpha 1A- and alpha 1D-adrenoceptor subtypes. Br J Pharmacol 120: 231-238.
28. O'Connell TD, Ishizaka S, Nakamura A, Swigart PM, Rodrigo MC, Simpson GL et al. (2003). The alpha(1A/C)- and alpha(1B)-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse. J Clin Invest 111: 1783-1791.
29. O'Connell TD, Swigart PM, Rodrigo MC, Ishizaka S, Joho S, Turnbull L et al. (2006). Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload. J Clin Invest 116: 1005-1015.
30. Ratnasooriya WD, Wadsworth RM (1990). Impairment of fertility of male rats with prazosin. Contraception 41: 441-447.
31. Rokosh DG, Simpson PC (2002). Knockout of the alpha 1A/C-adrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc Natl Acad Sci USA 99: 9474-9479.
32. Salomon L, Lanteri C, Glowinski J, Tassin JP (2006). Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons. Proc Natl Acad Sci USA 103: 7476-7481.
33. Spreng M, Cotecchia S, Schenk F (2001). A behavioral study of alpha-1b adrenergic receptor knockout mice: increased reaction to novelty and selectively reduced learning capacities. Neurobiol Learn Mem 75: 214-229.
34. Tambaro S, Ruiu S, Dessi C, Mongeau R, Marchese G, Pani L (2005). Evaluation of tamsulosin and alfuzosin activity in the rat vas deferens: relevance to ejaculation delays. J Pharmacol Exp Ther 312: 710-717.
35. Tanoue A, Koba M, Miyawaki S, Koshimizu TA, Hosoda C, Oshikawa S et al. (2002a). Role of the alpha1D-adrenergic receptor in the development of salt-induced hypertension. Hypertension 40: 101-106.
36. Tanoue A, Nasa Y, Koshimizu T, Shinoura H, Oshikawa S, Kawai T et al. (2002b). The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. J Clin Invest 109: 765-775.
37. van Dijk MM, de la Rosette JJ, Michel MC (2006). Effects of alpha(1)-adrenoceptor antagonists onmale sexual function. Drugs 66: 287-301.
38. Westfall TD, Westfall DP (2001). Pharmacological techniques for the in vitro study of the vas deferens. J Pharmacol Toxicol Methods 45: 109-122.
39. Wyllie MG (1999). Alpha1-adrenoceptor selectivity: the North American experience. Eur Urol 36 (Suppl 1): 59-63; discussion 65.